Skip to content
Screener

Bausch + Lomb BLCO Total Equity

Total Equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$84.97B+8.3%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$8.24B-0.6%
Glaukos logo
GlaukosGKOS
$682.49M-10.8%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$10.79M+149%
HRO
HarrowHROW
$28.71M-49.1%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$581.57M+119%

Other financials

Income statement

See full
Revenue$1.4B+9.1%
Operating income$83.0M+855%
Net income-$14.0M+77.4%
EPS (diluted)-$0.04+77.8%

Balance sheet

See full
Cash & equivalents$378.0M+39.0%
Total debt$5.1B+2.4%
Total assets$13.9B+0.2%

Cash flow

See full
Operating cash flow$153.0M+337%
CapEx$71.0M-20.2%
Free cash flow$82.0M+252%

Valuation

See full
Market cap$5.84B+17.0%
Enterprise value$10.54B+8.9%
P/S1.1×+0.1×

Profitability

See full
Operating margin6.1%+5.3pp
Net margin-3.2%-1.0pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-2.7%-0.7pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001860742-26-000088
Line itemJune 30, 2026December 31, 2025
Common shares, no par value, unlimited shares authorized, 357,057,005 and 354,209,319 issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital8,6108,563
Accumulated deficit(1,016)(931)
Accumulated other comprehensive loss(1,218)(1,184)
Total Bausch + Lomb Corporation shareholders’ equity6,3766,448
Noncontrolling interest6871
Total equity6,4446,519
Total liabilities and equity$13,859$14,022

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch + Lomb's total equity?
Bausch + Lomb (BLCO) reported total equity of $6.38B in Q2 2026.
How has Bausch + Lomb's total equity changed year-over-year?
Bausch + Lomb's total equity decreased by 1.0% year-over-year, from $6.44B to $6.38B.
What is the long-term trend for Bausch + Lomb's total equity?
Over 5 years (2020 to 2025), Bausch + Lomb's total equity has grown at a -8.4% compound annual growth rate (CAGR), from $9.99B to $6.45B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Bausch + Lomb's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude